Your account has been temporarily locked due to incorrect sign in attempts and will be automatically unlocked in
For immediate assistance, contact Customer Service:
800-638-3030 (within USA), 301-223-2300 (international)
Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Flash Player 9.0.0 is required for the Video Gallery.
Get Adobe Flash Player.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
Harvard Review of Psychiatry. 25(2):50-64, March/April 2017
A video abstract by Drs. Pieter-Jan Carpentier and Frances Levin, lead authors of a review article published in the March/April 2017 issue. ADHD is a risk factor for substance use disorders. Although pharmacotherapy is effective for childhood and adult ADHD, findings have been mixed in adolescent and adult ADHD patients with substance use disorders. In this brief video abstract, the authors discuss contributing factors and possible explanations, along with implications for future research and for clinical practice.